The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)

Completed · Not applicable

Conditions studied: Phenylketonuria

In brief

The purpose of this study is to determine if taking supplemental DHA improves measures of processing speed and executive function in teen and adult women with PKU.

Key facts

Study ID

NCT00892554

Run by

Emory University

People needed

33

Starts

2007-06-01

Expected to finish

2010-01-01

Last updated by the study team

2015-12-11

Who can join

Age: 12 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females
• Phenylketonuria
• Ages 12 years and older
• Able to complete neuropsychological testing

You may not qualify if…

• Pregnancy
• Currently taking DHA supplement

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.